The COVID-19 pandemic jump-started a significant role for telemedicine in the routine follow-up of US patients with type 2 diabetes, based on insurance-claims records for more than 2.7 million ...

Small practices reduced their use of telemedicine during early stages of the COVID-19 pandemic. Technical support may help expand and maintain telemedicine in small practices. Objectives: The COVID-19 ...

An endocrinology telehealth clinic successfully cut down travel time while decreasing glucose variability among Type 1 diabetes patients, according to a study published by the CDC on Jan. 25. For the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Latin American children with diabetes and access to ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The proportion of telemedicine visits at diabetes ...

In a recent blog post, American Well discusses diabetes care in the context of telehealth. More specifically, the post highlights the importance of integrating telehealth into diabetes care. Diabetes ...

Adult patients with type 2 diabetes and complex care needs receiving endocrinology treatment through telemedicine alone show worse glycemic outcomes compared with those receiving treatment either ...

Adults with type 2 diabetes (T2D) undergoing endocrinology care are more likely to experience less favorable hemoglobin A1c improvements if they only use telemedicine compared with patients using ...

The rapid adoption of telemedicine and increased use of continuous glucose monitoring helped to attenuate the impacts of the COVID-19 pandemic on children with Type 1 diabetes, according to a new ...

Diabetes afflicts more than 22 million Americans, or 7% of the total population, and the number of people diagnosed every year is skyrocketing. At a cost of $245 billion in 2012, the disease's toll on ...

New case studies show the benefits of remote management based on continuous glucose monitoring (CGM) and telemedicine visits for patients with type 1 and type 2 diabetes during the COVID-19 pandemic.